                         SEQUENCE LISTING

<110>  Guangzhou Medical University
 
<120>  Therapeutic substances for inflammatory diseases

<130>  ZMPCT22001

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  30
<212>  PRT
<213>  Human adenovirus type 1

<400>  1

Gly Gln Pro Pro Ser Gln Pro Pro Gln Gly Gln Gly Pro Pro Ser Gly 
1               5                   10                  15      


Pro Gly Gln Pro Ala Pro Ala Ala Thr Gln Ala Ala Pro Gln 
            20                  25                  30  


<210>  2
<211>  15
<212>  PRT
<213>  Human adenovirus type 1

<400>  2

Gln Pro Pro Gly Gln Gly Pro Pro Ser Gly Pro Gly Gln Pro Ala 
1               5                   10                  15  


<210>  3
<211>  20
<212>  PRT
<213>  Human adenovirus type 1

<400>  3

Arg Gln Ala Met Arg Ile Asn Ile Asn Pro Ser Thr Ala Asn Ser Pro 
1               5                   10                  15      


Lys Cys Gln Glu 
            20  


<210>  4
<211>  34
<212>  PRT
<213>  Human adenovirus type 1

<400>  4

Pro Pro Lys Gln Arg Cys Arg Ala Pro Ala Cys Asp His Phe Gly Asn 
1               5                   10                  15      


Ala Lys Cys Asn Gly Tyr Cys Asn Glu Cys Tyr Gln Phe Lys Gln Met 
            20                  25                  30          


Tyr Gly 
        


